Literature DB >> 10716680

Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression.

S Siavoshian1, J P Segain, M Kornprobst, C Bonnet, C Cherbut, J P Galmiche, H M Blottière.   

Abstract

BACKGROUND: Sodium butyrate, a product of colonic bacterial fermentation, is able to inhibit cell proliferation and to stimulate cell differentiation of colonic epithelial cell lines. It has been proposed that these cellular effects could be linked to its ability to cause hyperacetylation of histone through the inhibition of histone deacetylase. AIM: To analyse the molecular mechanisms of butyrate action on cell proliferation/differentiation and to compare them with those of trichostatin A, a well known inhibitor of histone deacetylase.
METHODS: HT-29 cells were grown in the absence or presence of butyrate or trichostatin A. Cell proliferation and cell cycle distribution were studied after DNA staining by crystal violet and propidium iodide respectively. Cell cycle regulatory proteins were studied by western blot and reverse transcription-polymerase chain reaction. Cell differentiation was followed by measuring brush border enzyme activities. Histone acetylation was studied by acid/urea/Triton acrylamide gel electrophoresis.
RESULTS: Butyrate blocked cells mainly in the G(1) phase of the cell cycle, whereas trichostatin A was inhibitory in both G(1) and G(2) phases. Butyrate inhibited the mRNA expression of cyclin D1 without affecting its protein expression and stimulated the protein expression of cyclin D3 without affecting its mRNA expression. Trichostatin A showed similar effects on cyclin D1 and D3. Butyrate and trichostatin A stimulated p21 expression both at the mRNA and protein levels, whereas their effects on the expression of cyclin dependent kinases were slightly different. Moreover, butyrate strongly stimulated the activity of alkaline phosphatase and dipeptidyl peptidase IV, whereas trichostatin A had no effect. Finally, a six hour exposure to butyrate or trichostatin A induced histone H4 hyperacetylation. At 15 and 24 hours, histone H4 remained hyperacetylated in the presence of butyrate, whereas it returned to control levels in the presence of trichostatin A.
CONCLUSIONS: The data may explain how butyrate acts on cell proliferation/differentiation, and they show that trichostatin A does not reproduce every effect of butyrate, mainly because of its shorter half life.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10716680      PMCID: PMC1727889          DOI: 10.1136/gut.46.4.507

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  45 in total

1.  Expression of the positive regulator of cell cycle progression, cyclin D3, is induced during differentiation of myoblasts into quiescent myotubes.

Authors:  M Kiess; R M Gill; P A Hamel
Journal:  Oncogene       Date:  1995-01-05       Impact factor: 9.867

2.  Stimulation of tissue-type plasminogen activator gene expression by sodium butyrate and trichostatin A in human endothelial cells involves histone acetylation.

Authors:  J Arts; M Lansink; J Grimbergen; K H Toet; T Kooistra
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

3.  Induction of p21 (WAF-1/CIP1) during differentiation.

Authors:  R A Steinman; B Hoffman; A Iro; C Guillouf; D A Liebermann; M E el-Houseini
Journal:  Oncogene       Date:  1994-11       Impact factor: 9.867

4.  Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53.

Authors:  H Jiang; J Lin; Z Z Su; F R Collart; E Huberman; P B Fisher
Journal:  Oncogene       Date:  1994-11       Impact factor: 9.867

5.  Polymorphisms and probable lack of mutation in the WAF1-CIP1 gene in colorectal cancer.

Authors:  Y J Li; P Laurent-Puig; R J Salmon; G Thomas; R Hamelin
Journal:  Oncogene       Date:  1995-02-02       Impact factor: 9.867

6.  Apoptosis in colorectal tumour cells: induction by the short chain fatty acids butyrate, propionate and acetate and by the bile salt deoxycholate.

Authors:  A Hague; D J Elder; D J Hicks; C Paraskeva
Journal:  Int J Cancer       Date:  1995-01-27       Impact factor: 7.396

7.  Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues.

Authors:  W S el-Deiry; T Tokino; T Waldman; J D Oliner; V E Velculescu; M Burrell; D E Hill; E Healy; J L Rees; S R Hamilton
Journal:  Cancer Res       Date:  1995-07-01       Impact factor: 12.701

8.  An interleukin 2/sodium butyrate combination as immunotherapy for rat colon cancer peritoneal carcinomatosis.

Authors:  P Perrin; E Cassagnau; C Burg; Y Patry; F Vavasseur; J Harb; J Le Pendu; J Y Douillard; J P Galmiche; F Bornet
Journal:  Gastroenterology       Date:  1994-12       Impact factor: 22.682

9.  Inhibition of cyclin-dependent kinases by p21.

Authors:  J W Harper; S J Elledge; K Keyomarsi; B Dynlacht; L H Tsai; P Zhang; S Dobrowolski; C Bai; L Connell-Crowley; E Swindell
Journal:  Mol Biol Cell       Date:  1995-04       Impact factor: 4.138

10.  Human dipeptidyl peptidase IV gene promoter: tissue-specific regulation from a TATA-less GC-rich sequence characteristic of a housekeeping gene promoter.

Authors:  S K Böhm; J R Gum; R H Erickson; J W Hicks; Y S Kim
Journal:  Biochem J       Date:  1995-11-01       Impact factor: 3.857

View more
  62 in total

1.  Butyrate, an HDAC inhibitor, stimulates interplay between different posttranslational modifications of histone H3 and differently alters G1-specific cell cycle proteins in vascular smooth muscle cells.

Authors:  Omana P Mathew; Kasturi Ranganna; Frank M Yatsu
Journal:  Biomed Pharmacother       Date:  2010-12       Impact factor: 6.529

Review 2.  Do probiotics have a therapeutic role in gastroenterology?

Authors:  Jimmy K Limdi; Catherine O'Neill; John McLaughlin
Journal:  World J Gastroenterol       Date:  2006-09-14       Impact factor: 5.742

Review 3.  A potential role of probiotics in colorectal cancer prevention: review of possible mechanisms of action.

Authors:  Esther Swee Lan Chong
Journal:  World J Microbiol Biotechnol       Date:  2013-09-26       Impact factor: 3.312

4.  Upregulation of STAT3 marks Burkitt lymphoma cells refractory to Epstein-Barr virus lytic cycle induction by HDAC inhibitors.

Authors:  Derek Daigle; Cynthia Megyola; Ayman El-Guindy; Lyn Gradoville; David Tuck; George Miller; Sumita Bhaduri-McIntosh
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

5.  In vitro effects of cholesteryl butyrate solid lipid nanospheres as a butyric acid pro-drug on melanoma cells: evaluation of antiproliferative activity and apoptosis induction.

Authors:  B Salomone; R Ponti; M R Gasco; E Ugazio; P Quaglino; S Osella-Abate; M G Bernengo
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

Review 6.  Collateral damage: microbiota-derived metabolites and immune function in the antibiotic era.

Authors:  Christopher A Lopez; Dawn D Kingsbury; Eric M Velazquez; Andreas J Bäumler
Journal:  Cell Host Microbe       Date:  2014-08-13       Impact factor: 21.023

7.  Histone deacetylase inhibition results in a common metabolic profile associated with HT29 differentiation.

Authors:  Gema Alcarraz-Vizán; Joan Boren; Wai-Nang Paul Lee; Marta Cascante
Journal:  Metabolomics       Date:  2010-01-08       Impact factor: 4.290

8.  Sp1 acetylation is associated with loss of DNA binding at promoters associated with cell cycle arrest and cell death in a colon cell line.

Authors:  Jennifer S Waby; Haridasan Chirakkal; ChenWei Yu; Gareth J Griffiths; Roderick S P Benson; Colin D Bingle; Bernard M Corfe
Journal:  Mol Cancer       Date:  2010-10-15       Impact factor: 27.401

9.  IGFBP-rP1, a potential molecule associated with colon cancer differentiation.

Authors:  Wenjing Ruan; Shuzhen Zhu; Haibing Wang; Fangying Xu; Hong Deng; Yu Ma; Maode Lai
Journal:  Mol Cancer       Date:  2010-10-26       Impact factor: 27.401

10.  Effects of the in vivo supply of butyrate on histone acetylation of cecum in piglets.

Authors:  C Lawrence Kien; Cheryl P Peltier; Soma Mandal; James R Davie; Ruth Blauwiekel
Journal:  JPEN J Parenter Enteral Nutr       Date:  2008 Jan-Feb       Impact factor: 4.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.